Introduction
conserved motif of cysteine residues and is Chemoattractants are key components of the classified according to the relative positions of immune system, being involved in the trafficking, the first of these as C, CC, CXC and most localization and activation of leucocytes. T h e recently CX3C [ 11 chemokines. Many leucocyte agents involved include bacterial formylpeptides, chemoattractant receptors have now been cloned the complement fragment CSa, platelet-activating (Table 1 ) and shown to belong to the sevenfactor (PAF) and leukotriene B4. More recently transmembrane-domain-G-protein-coupled rethese 'classical' chemoattractants have been ceptor superfamily (STRs). Generally the classieclipsed by an ever-expanding family of chemocal chemoattractant receptors exhibit a singletactic cytokines or chemokines. This family has a ligand specificity, whereas the chemokine receptors are much more promiscuous. T h e overall structure is exemplified by that of the C5a receptor (C5aR) shown in Figure 1 . Chemo Moreover various 'leucocyte' chemoattractant receptors are now known to be expressed by a variety of other tissues and cell types including spleen, heart, lung, kidney, intestine and brain on alveolar epithelial cells, vascular smooth-muscle and endothelial cells, astrocytes and microglia [S-81. In the vasculature these receptors may well facilitate leucocvte trafficking by the presentation of attractants and the up-regulation of
Model structure of the C5aR
Residues mentioned in the text are highlighted. CHO, N-linked glycosylation site; 0 1 -3, outer loops 1-3; I 1-3, inner loops 1-3.
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various adhesion molecules; however, the role of chemoattractant receptors in some of these other tissues, such as the brain, is the subject of much speculation.
Clearly a detailed structural and functional analysis of this ever-expanding family of receptors is of great interest. Not only will this further our understanding of the role these molecules play in the immune response, but it should also facilitate the rational design of receptor antagonists, which may be of great therapeutic potential in the treatment of a variety of widespread and life-threatening disorders.
Ligand-binding sites
The CSoR model
One of the earliest leucocyte chemoattractant receptors to be cloned was that for the complement fragment C5a [9] . As the parent molecule, C5 is constantly present in serum, and, because most invading micro-organisms activate the complement system, C5a and its cleavage product, de~-Arg'~-C5a, are probably the major leucocyte chemoattractants. Initial work in our laboratory was directed at attempting to identify the ligandbinding site on this receptor. Earlier work involving mutagenesis of human C5a (hC5a) suggested that this would be far from straightforward. These data indicated that three discontiguous regions of hC5a were necessary for high-affinity binding [lo] . At the C-terminus of hC5a, mutation of L Y S~~, Leu7' or Arg74 substantially inhibits binding, and substitution of Gly for Arg40 in the disulphide-linked core of hC5a and mutation of some N-terminal residues also affects binding affinity. It seemed likely therefore that the ligand would interact with multiple sites on the C5aR. Initial experiments in our laboratory using C5aR/ formyl peptide receptor (FPR) chimaeras confirmed this expectation [ 113.
Subsequent studies with antibodies against the hC5a receptor [12, 13] and receptor mutations [14, 15] have highlighted the role of the receptor N-terminus, containing a number of aspartate residues (which may interact with the basic C5a), in ligand binding. It has been shown that, although the receptor N-terminus is required for high-affinity binding of hC5a, it is not essential for receptor activation, providing evidence that at least two receptor sites are involved in the interaction with ligand [13, 14] . Peptides that mimic the C-terminal region of hC5a retain full ability to bind to mutated hC5aR in which the first 22 residues of the receptor N-terminus have been deleted; hC5a itself binds to this mutant with nearly a 1000-fold lower affinity compared with wild-type receptor [ 151. Receptor mutation was carried out in our laboratory and elsewhere in order to identify this putative activation site on the receptor. As two basic residues, and Arg74, in the C-terminus of C5a had already been shown to be important for interaction with the receptor, our approach was to mutate potential counter ions, exposed aspartate and glutamate residues, on the receptor to their corresponding amines. For example, from modelling studies [ 161 it had been proposed that Asps2 (a highly conserved residue in the second transmembrane-spanning helix of G-proteincoupled receptors and which interacts with ligand in some) may be the counter ion to Arg74 of C5a. Mutation of this residue to an asparagine was without effect on ligand binding, but did inhibit signal transduction of the receptor expressed in rat basophilic leukaemia cells (RBL-2H3) [17, 18] . However, expression of a C5aR in which G~u '~~ had been changed to a glutamine ([Gln1w]C5aR) in the same system resulted in a decreased receptor affinity and signalling response to both C5a and a peptide corresponding to the C5a C-terminus [19] . The binding and potency of intact C5a is considerably greater than the natural cleavage product desThis difference was maintained in the [Gln'99]C5aR mutant, indicating that the interaction of the receptor with Arg74 of C5a remained unchanged by this mutation. In contrast, mutating the equivalent of in a peptide corresponding to the C-terminus of C5a to a methionine inhibited its potency with respect to the wild-type receptor but not the [Glr1'~~]C5aR mutant, implicating of C5a as the counter ion of G~u '~~ on the receptor. We have now confirmed these results by a direct exchange of the Lys@ of de~-Arg~~-C5a and G~u '~~ of the receptor. Similar C5a C-terminal peptides were used by others [20] to establish a potential interaction between A r e 6 of C5aR and Arg74 of C5a. This work indicates that the terminal carboxy group of these peptides is able to negate the expected repulsion between the two positively charged guanidino side chains and activate the receptor.
Although mutation of Arg206 also has some effect on the potency of intact C5a, no comparisons were made with de~-Arg~~-CSa to ascertain whether this interaction is directly applicable to the native ligand. Other workers have presented evidence that Argo6 determines binding of the
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human CSaR by affecting the intracellular G-protein coupling [21] .
Chemokine receptors
This paradigm of multiple and often distinct binding and activation domains on both ligand and receptor appears to be mirrored by the chemokines. For example, the ELR motif of CXC chemokines such as IL-8 is essential for both binding and activation of CXCRs; however, ELRcontaining peptides fail to bind these receptors, indicating the existence of further sites [22] . This has been confirmed by the construction of receptor chimaeras, which indicate that CXCbinding determinants are distributed on multiple domains of CXCRl and 2 and that high-affinity determinants can be distinguished from those required for receptor activation [23] . Likewise CC chemokines have been shown to have distinguishable binding and activating determinants [22] , and, for the CCR2B receptor at least, this is reflected in the receptor [24] .
Chemoattractant receptor coupling
Despite the fact that leucocyte chemoattractants vary enormously in structure, the functional responses of their receptors are remarkably similar and appear to share many common signalling pathways [25] . Most cellular responses to chemoattractants can be inhibited by pertussis toxin treatment and, consistent with this, Gi2 and Gi3 are found in cells expressing these receptors. However, CSa-induced responses in monocytic cells show differential sensitivity to pertussis toxin [26] , and the PAFR, for example, is able to couple to both pertussis toxin-sensitive and -insensitive G-proteins [27] . In addition monomeric G-proteins (of the Ras family, for example) have been linked to certain chemoattractant-induced responses [25] .
The structural elements involved in coupling chemoattractant receptors to these G-proteins have yet to be precisely determined. Detailed analysis of other STR family members has implicated regions of 12, the C-terminus and particularly I3 (see Figure 1 ) in G-protein coupling [28] . Unusually, for FPRs at least, I3 does not appear to play a role in G-protein interaction [29] . In these latter receptors 11, I2 and the C-terminus have been implicated [30, 31] . In contrast, the PAFR I3 appears to be essential for inositol phosphate production [ 321.
In addition to differences in G-protein coupling, detailed examination of chemoattractant receptors has also revealed subtle variations in functional responses. For example in neutrophils, PAF and leukotriene B4, although efficient at stimulating chemotaxis, are relatively poor activators of the respiratory burst compared with CSa or fMLF (reviewed in [33] ). IL-8 occupies an intermediate position; the respiratory burst is induced but other responses, such as the production of PAF are only weakly activated [34] .
In our laboratory we have begun to explore these differences by expressing various chemoattractant receptors and chemoattractant receptor constructs in RBL 2H3 cells and examining functional responses. In this system CSaR, FPR and PAFR couple efficiently to both pertussis toxin-sensitive (CSaR, FPR) and -insensitive (PAFR) secretion pathways, whereas CXCRl couples poorly. Provisional data indicate that these differences may be attributable to differences in the rates at which these receptors are internalized. CXCRl is internalized much more rapidly than CSaR, whereas truncation of part of the C-terminus of CXCRl inhibits internalization and enhances secretion. The C-terminus appears to be critical in the internalization of a variety of STRs and this is also the case for CSaR, CXCRl and CXCR2 [35, 36] . However, we found that a CXCRl/CSaR chimaera, in which the whole of the CXCRl C-terminus was replaced with that of the CSaR, was also internalized very rapidly, indicating that regions other than the C-termini are also important in governing internalization rate.
Concluding remarks
The binding of chemoattractant to its receptor elicits a vital and yet potentially hazardous series of cellular responses. Although controlling these responses is of great therapeutic potential, the task is fraught with difficulties. What seemed at one time to be a relatively small family of molecules has grown out of all proportion, with receptor promiscuity and potential ligand redundancy commonplace. This is further exacerbated by the finding that the nature of the interaction between ligand and receptor is complex and involves multiple sites. The apparently common signalling responses shared by these receptors offers the hope that antagonism of multiple attractant receptors may yet be a possibility; however, here also many differences are now becoming apparent. Establishing common structure-function relationships in the chemoattract-
